Publications:

A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.

The Oncologist

T Danley, Kelsey K; Schmitz, Karen K; Ghai, Ritu R; Sclamberg, Joy S JS; Buckingham, Lela E LE; Burgess, Kelly K; Kuzel, Timothy M TM; Usha, Lydia L

Publication Date: 2021-10

Variant appearance in text: MSH6: 3848_3851del; I1283fs

PubMed Link: 34018286

Variant Present in the following documents:

• Main text

View BVdb publication page